Assay interference and off-target liabilities of reported histone acetyltransferase inhibitors
A substantial obstacle in basic research is the use of poorly validated tool compounds with purported useful biological functions. Here, the authors systematically profile widely used histone acetyltransferase inhibitors and find that the majority are nonselective interference compounds.
Saved in:
Main Authors: | Jayme L. Dahlin, Kathryn M. Nelson, Jessica M. Strasser, Dalia Barsyte-Lovejoy, Magdalena M. Szewczyk, Shawna Organ, Matthew Cuellar, Gurpreet Singh, Jonathan H. Shrimp, Nghi Nguyen, Jordan L. Meier, Cheryl H. Arrowsmith, Peter J. Brown, Jonathan B. Baell, Michael A. Walters |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2017
|
Subjects: | |
Online Access: | https://doaj.org/article/8ca9ff19d5524b75acdb413bf0ff0f30 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
- Products Liability
-
Risk management of contingent liabilities within a sovereign asset-liability framework
by: Currie, Elizabeth, et al.
Published: (2014) -
Journal of products and toxics liability
Published: (1993) - Professional Liability Litigation @lert
- Professional Services Liability Litigation